Complement association with neurons and β-amyloid deposition in the brains of aged individuals with down syndrome

被引:81
作者
Head, E [1 ]
Azizeh, BY
Lott, IT
Tenner, AJ
Cotman, CW
Cribbs, DH
机构
[1] Univ Calif Irvine, Inst Brain Aging & Dementia, Irvine, CA 92697 USA
[2] Univ Calif Irvine, Mental Retardat Ctr, Dept Pediat, Irvine, CA 92697 USA
[3] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA
关键词
Alzheimer's disease; beta-amyloid; C1q; complement; microglia; neuroinflammation; senile plaques; trisomy; 21;
D O I
10.1006/nbdi.2000.0380
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
To study the link between beta -amyloid (A beta) and neuroinflammation, we examined the levels of complement as a function of age and extent of AP deposition in Down Syndrome (DS) brain. C1q, the first component of the complement cascade, was visualized using immunohistochemistry in the frontal, entorhinal cortex, and hippocampus of 12 DS ranging from 31 to 69 years of age. C1q was consistently associated with thioflavine-S positive A beta plaques in DS brain and increased with more extensive age-dependent. A beta deposition. In contrast, little or no C1q labeling was associated with diffuse or thiofiavine-S negative A beta deposits. Neurons in the hippocampus and entorhinal cortex, but less frequently in frontal cortex, were C1q positive in DS cases with sufficient neuropathology to have a diagnosis of Alzheimer's disease. C1q-positive neurons were associated with activated microglia. These results provide evidence for A beta -mediated inflammatory factors contributing to the rapid accumulation of neuropathology in DS brain. (C) 2001 Academic Press.
引用
收藏
页码:252 / 265
页数:14
相关论文
共 64 条
[1]   Localization and cell association of C1q in Alzheimer's disease brain [J].
Afagh, A ;
Cummings, BJ ;
Cribbs, DH ;
Cotman, CW ;
Tenner, AJ .
EXPERIMENTAL NEUROLOGY, 1996, 138 (01) :22-32
[2]  
Armstrong R A, 1994, Neurobiol Dis, V1, P139, DOI 10.1006/nbdi.1994.0017
[3]   Molecular dating of senile plaques in the drains of individuals with Down syndrome and in aged dogs [J].
Azizeh, BY ;
Head, E ;
Ibrahim, MA ;
Torp, R ;
Tenner, AJ ;
Kim, RC ;
Lott, IT ;
Cotman, CW .
EXPERIMENTAL NEUROLOGY, 2000, 163 (01) :111-122
[4]   COMPLEMENT BIOSYNTHESIS IN THE CENTRAL-NERVOUS-SYSTEM [J].
BARNUM, SR .
CRITICAL REVIEWS IN ORAL BIOLOGY AND MEDICINE, 1995, 6 (02) :132-146
[5]   STAGING OF ALZHEIMERS-DISEASE-RELATED NEUROFIBRILLARY CHANGES [J].
BRAAK, H ;
BRAAK, E .
NEUROBIOLOGY OF AGING, 1995, 16 (03) :271-278
[6]   NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES [J].
BRAAK, H ;
BRAAK, E .
ACTA NEUROPATHOLOGICA, 1991, 82 (04) :239-259
[7]   MORPHOMETRIC ANALYSIS OF MICROGLIA IN ALZHEIMERS-DISEASE [J].
CARPENTER, AF ;
CARPENTER, PW ;
MARKESBERY, WR .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1993, 52 (06) :601-608
[8]   Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid β-peptide by microglial cells [J].
Chung, HY ;
Brazil, MI ;
Soe, TT ;
Maxfield, FR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (45) :32301-32308
[9]  
Cotman CW, 1996, NEUROBIOL AGING, V17, P723
[10]   THE NEUROBIOLOGICAL CONSEQUENCES OF DOWN-SYNDROME [J].
COYLE, JT ;
OSTERGRANITE, ML ;
GEARHART, JD .
BRAIN RESEARCH BULLETIN, 1986, 16 (06) :773-787